FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

15457211000001106: Concord 693 250mg capsules (Archimedes Pharma Products Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
54762001000001116 Concord 693 250mg capsules (Archimedes Pharma Products Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100638601000001113 Concord 693 250mg capsules (Kyowa Kirin Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Concord 693 250mg capsules (Archimedes Pharma Products Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Concord 693 250mg capsules (Archimedes Pharma Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction individual patient supply true Inferred relationship Existential restriction modifier
Concord 693 250mg capsules (Archimedes Pharma Products Ltd) Is a Sulfapyridine 250mg capsules true Inferred relationship Existential restriction modifier
Concord 693 250mg capsules (Archimedes Pharma Products Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Concord 693 250mg capsules (Archimedes Pharma Products Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Concord 693 250mg capsules (Archimedes Pharma Products Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Concord 693 250mg capsules (Archimedes Pharma Products Ltd) Is a Concord 693 true Inferred relationship Existential restriction modifier
Concord 693 250mg capsules (Archimedes Pharma Products Ltd) Has specific active ingredient Sulfapyridine true Inferred relationship Existential restriction modifier
Concord 693 250mg capsules (Archimedes Pharma Products Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Concord 693 250mg capsules (Archimedes Pharma Products Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Concord 693 250mg capsules (Archimedes Pharma Products Ltd) Has active ingredient Substance with sulfonamide structure and antibacterial mechanism of action true Inferred relationship Existential restriction modifier
Concord 693 250mg capsules (Archimedes Pharma Products Ltd) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Concord 693 250mg capsules (Archimedes Pharma Products Ltd) 100 capsule Has AMP True Concord 693 250mg capsules (Archimedes Pharma Products Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start